Clinical Study

Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms

Table 2

Comparisons of IPSS/QoL, VAP scale, and OAB-q scores in all groups.

Group IGroup IIGroup IIIGroup IV value
C groupT groupS groupT/S group

IPSS (storage symptom score)
 Preinsertion 0.989
 2 weeks after insertion 0.000
IPSS (voiding symptom score)
 Preinsertion 0.988
 2 weeks after insertion 0.000
IPSS (total score)
 Preinsertion 0.986
 2 weeks after insertion 0.000
Qol score
 Preinsertion 0.862
 2 weeks after insertion 0.000
OAB-q score
 Preinsertion 0.255
 2 weeks after insertion 0.000
VAPS score
 Preinsertion 0.172
 2 weeks after insertion 0.000

IPSS: International Prostate Symptom Score; QoL: quality of life; OAB-q: Overactive Bladder Questionnaire; VAPS: Visual Analogue Pain Scale.